Notably, the adiponectin receptor (AdipoR) agonist AdipoRon can activate the AMPK/adiponectin/PPAR-α signalling pathway in muscles and liver, thereby counteracting the detrimental effects of obesity [23]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.